Effects of Recombinant Human Glutamic Acid Decarboxylase . . .
A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT
Detection of C-peptide in Youth With Longstanding Type 1 Diabetes Mellitus
† Indicates status has not been verified in more than two years